Protocol summary

Study aim
Comparison of Ketamin/Propofol (Ketofol) and Etomidate /Fentanyl (Etofen) combinations for procedural sedation and analgesia of anterior shoulder dislocation reduction in Emergency Department
Design
A clinical trial with two parallel groups of Ketofol and Etofen, single-blind, randomized, phase 2 on 46 patients. The patients will be randomly assigned to one of the Ketofol or Etofen groups. Randomization is done using a table of random numbers and by the block randomization method.
Settings and conduct
This study is conducted on patients who referred to the emergency department of Shahid Bahonar Hospital in Kerman. The patients will be randomly assigned to one of the Ketofol or Etofen groups. According to the PSAs protocol, Ketofol with a dose of 0.75 mg/kg IV bolus of ketamine and propofol, etofen with a dose of 0.15 mg/kg IV bolus of etomidate and 0.15 µg/kg of fentanyl are given as starting doses. A repeat dose of 0.375 mg/kg ketamine and propofol every 3 minutes and 0.1 mg/kg etomidate every 2 minutes is given until adequate sedation is achieved.
Participants/Inclusion and exclusion criteria
Inclusion criteria: Adults between 18 and 50 years old with anterior shoulder dislocation Exclusion criteria: History of allergy to any of the drugs, underlying cardiovascular disease, lung diseases and nervous system diseases, history of current drug or stimulant abuse now or in the last month, associated fracture, neurovascular symptoms, patient dissatisfaction, associated diseases
Intervention groups
According to the PSAs protocol, bolus of ketamine and propofol for Ketofol Group, bolus of etomidate and fentanyl for Etofen group are given as sedation.
Main outcome variables
Pain score; number of attempts for reduction ; length of stay in the emergency; Drug side effects;

General information

Reason for update
Acronym
IRCT registration information
IRCT registration number: IRCT20220824055790N1
Registration date: 2022-09-13, 1401/06/22
Registration timing: prospective

Last update: 2022-09-13, 1401/06/22
Update count: 0
Registration date
2022-09-13, 1401/06/22
Registrant information
Name
Seyed Mojtaba Habibi Khorasani
Name of organization / entity
Country
Iran (Islamic Republic of)
Phone
+98 34 3244 3126
Email address
mojista.1375@gmail.com
Recruitment status
Recruitment complete
Funding source
Expected recruitment start date
2022-10-23, 1401/08/01
Expected recruitment end date
2023-03-20, 1401/12/29
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Comparison of Ketamin/Propofol (Ketofol) and Etomidate /Fentanyl (Etofen) combinations for procedural sedation and analgesia of anterior shoulder dislocation reduction in Emergency Department: A Randomized Clinical Trial
Public title
Comparison of Ketamin/Propofol (Ketofol) and Etomidate /Fentanyl (Etofen) in reduction of shoulder dislocation
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria:
Adults between 18 and 50 years old Anterior shoulder dislocation
Exclusion criteria:
History of allergy to any of the drugs (ketamine, propofol, etomidate, fentanyl) underlying cardiovascular disease lung diseases nervous system diseases (central or peripheral) history of current drug or stimulant abuse now or in the last month associated fracture neurovascular symptoms patient dissatisfaction associated diseases
Age
From 18 years old to 50 years old
Gender
Both
Phase
2-3
Groups that have been masked
  • Participant
Sample size
Target sample size: 46
Randomization (investigator's opinion)
Randomized
Randomization description
The patients will be randomly assigned to one of the Ketofol or Etofen groups. Randomization is done using a table of random numbers and by the block randomization method and in blocks of 5 people. In this way, a number is blindly selected from the table of random numbers for each position, and the two digits on the right side of it, if they are between 1 and 46, will be assigned to that position. Each of the blocks of 5 people is assigned to one group (Ketofol or Etofen). The odd blocks belong to the Ketofol group and the even blocks belong to the Etofen group. Block positions are numbered (1 to 46). For example, the first case that is randomly assigned to Ketofol group will enter the number one position of the first block (the block related to Ketofol) and this process will be done until the positions are filled and the number of samples in the two groups will be equal. .
Blinding (investigator's opinion)
Single blinded
Blinding description
Ketamin and Fentanyl drugs are colorless and have no difference in color, and the patient does not know which compound is being injected. Propofol is milky. Etomidate is available in two milky and colorless forms. A milky etomidate is used for the study to be similar to Propofol. Therefore, in each of the study groups, a colorless compound + a milky compound is used, and the patient is unaware of the type of drug.
Placebo
Not used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics commitee of Kerman Medical University
Street address
University of Medical Sciences, The beginning of Haft Bagh Alavi axis, Kerman
City
Kerman
Province
Kerman
Postal code
7616913555
Approval date
2022-07-31, 1401/05/09
Ethics committee reference number
IR.KMU.AH.REC.1401.081

Health conditions studied

1

Description of health condition studied
Anterior Shoulder Dislocation
ICD-10 code
S43.0
ICD-10 code description
Subluxation and dislocation of shoulder joint

Primary outcomes

1

Description
Pain score: using numerical rating scale
Timepoint
During Reduction
Method of measurement
Ask the patient: Score from 1 to 10

2

Description
Number of reduction attempts until reduction succeeds.
Timepoint
During study until reduction succeeds.
Method of measurement
-

3

Description
Length of stay in the emergency room: the time between the patient's admission to the emergency room and discharge
Timepoint
After discharge
Method of measurement
View the patient file

4

Description
Drug side effects: bradycardia, respiratory depression, hypotension
Timepoint
During Study
Method of measurement
Based on the form of drug side effects

Secondary outcomes

empty

Intervention groups

1

Description
Intervention group: According to the PSAs protocol, Ketofol with a dose of 0.75 mg/kg IV bolus of ketamine and propofol are given as starting doses. A repeat dose of 0.375 mg/kg ketamine and propofol every 3 minutes is given until adequate sedation is achieved. The goal of sedation in this study is to reach the patient's level of moderate sedation. The patient is apparently unconscious, but reacts with skin irritation. After the patient reaches the appropriate level of sedation, the emergency physician performs the sedation using the Liddle Meyer maneuver. And in case of failure, the same maneuver is repeated once more, and if it is still not successful, the next maneuver is traction. After successful reduction, the pain score, the number of reduction attempts, and the length of stay in the emergency room are measured.
Category
Treatment - Drugs

2

Description
Intervention group: According to the PSAs protocol, Etofen with a dose of 0.15 mg/kg IV bolus of etomidate and 0.15 µg/kg of fentanyl are given as starting doses. A repeat dose of 0.1 mg/kg etomidate every 2 minutes is given until adequate sedation is achieved. The goal of sedation in this study is to reach the patient's level of moderate sedation. The patient is apparently unconscious, but reacts with skin irritation. After the patient reaches the appropriate level of sedation, the emergency physician performs the sedation using the Liddle Meyer maneuver. And in case of failure, the same maneuver is repeated once more, and if it is still not successful, the next maneuver is traction. After successful reduction, the pain score, the number of reduction attempts, and the length of stay in the emergency room are measured.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
Shahid Bahonar Hospital
Full name of responsible person
Masoumeh Nazemi Rafei
Street address
Shahid Bahonar Hospital, Gharani St
City
Kerman
Province
Kerman
Postal code
7613747181
Phone
+98 34 3223 5011
Email
mojista.1375@gmail.com

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Reza Malekpour Afshar
Street address
Vice Chancellor of Research and Technology, Ebn-e-Sina St. ,Jahad Blvd.
City
Kerman
Province
Kerman
Postal code
7619813159
Phone
+98 34 3226 3719
Email
vcr@kmu.ac.ir
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Kerman University of Medical Sciences
Proportion provided by this source
100
Public or private sector
Public
Domestic or foreign origin
Domestic
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
Academic

Person responsible for general inquiries

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Seyed Mojtaba Habibi Khorasani
Position
Medical Student (Intern)
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Shahid Bahonar Hospital
City
Kerman
Province
Kerman
Postal code
7613747181
Phone
+98 34 3223 5011
Email
mojista.1375@gmail.com

Person responsible for scientific inquiries

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Masoumeh Nazemi Rafei
Position
Assistant Professor
Latest degree
Specialist
Other areas of specialty/work
Emergency Medicine
Street address
Shahid Bahonar Hospital
City
Kerman
Province
Kerman
Postal code
7613747181
Phone
+98 34 3223 5011
Email
m_nazemi_r@yahoo.com

Person responsible for updating data

Contact
Name of organization / entity
Kerman University of Medical Sciences
Full name of responsible person
Seyed Mojtaba Habibi Khorasani
Position
Medical Student (Intern)
Latest degree
A Level or less
Other areas of specialty/work
General Practitioner
Street address
Shahid Bahonar Hospital
City
Kerman
Province
Kerman
Postal code
7613747181
Phone
+98 34 3223 5011
Email
mojista.1375@gmail.com

Sharing plan

Deidentified Individual Participant Data Set (IPD)
Yes - There is a plan to make this available
Study Protocol
Yes - There is a plan to make this available
Statistical Analysis Plan
Undecided - It is not yet known if there will be a plan to make this available
Informed Consent Form
Undecided - It is not yet known if there will be a plan to make this available
Clinical Study Report
Undecided - It is not yet known if there will be a plan to make this available
Analytic Code
Undecided - It is not yet known if there will be a plan to make this available
Data Dictionary
Undecided - It is not yet known if there will be a plan to make this available
Title and more details about the data/document
Measured variables are available after unidentifiable individuals.
When the data will become available and for how long
Up to one year after publish results.
To whom data/document is available
All people in the research centers.
Under which criteria data/document could be used
Allowed for any use.
From where data/document is obtainable
Seyed Mojtaba Habibi Khorasani mojista.1375@gmail.com
What processes are involved for a request to access data/document
After contacting and knowing the identity of the person, information will be provided to them.
Comments
Loading...